1. |
Global tuberculosis report 2021[R]. Geneva: World Health Organization; 2021.
|
2. |
Kethireddy S, Light RB, Mirzanejad Y, et al. Mycobacterium tuberculosis septic shock. Chest, 2013, 144(2): 474-482.
|
3. |
Duro RP, Figueiredo Dias P, Ferreira AA, et al. Severe tuberculosis requiring intensive care: a descriptive analysis. Crit Care Res Pract, 2017, 2017: 9535463.
|
4. |
Saradna A, Shenoy A, Ambesh P, et al. Strongyloides hyperinfection and miliary tuberculosis presenting with syndrome of inappropriate antidiuretic hormone secretion in a malnourished patient. Cureus, 2018, 10(3): e2349.
|
5. |
Mishra R, Patel HK, Singasani R, et al. Tuberculosis septic shock, an elusive pathophysiology and hurdles in management: a case report and review of literature. World J Crit Care Med, 2019, 8(5): 72-81.
|
6. |
Zhang PZ, Xiong J, Zeng JF, et al. Clinical evaluation of active tuberculosis-related deaths in Shenzhen, China: a descriptive study. Int J Gen Med, 2021, 14: 237-242.
|
7. |
Ohmura SI, Ishihara R, Mitsui A, et al. A fatal case of concurrent disseminated tuberculosis, pneumocystis pneumonia, and bacterial septic shock in a patient with rheumatoid arthritis receiving methotrexate, glucocorticoid, and tocilizumab: an autopsy report. Case Rep Rheumatol, 2021, 2021: 7842049.
|
8. |
Getnet F, Demissie M, Assefa N, et al. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med, 2017, 17(1): 202.
|
9. |
Virenfeldt J, Rudolf F, Camara C, et al. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ Open, 2014, 4(6): e004818.
|
10. |
Penner C, Roberts D, Kunimoto D, et al. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med, 1995, 151: 867-872.
|
11. |
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA, 2012, 307(23): 2526-2533.
|
12. |
Chaudhry D, Tyagi D. Tuberculosis in intensive care unit. Indian J Crit Care Med, 2021, 25(Suppl 2): S150-S154.
|
13. |
Fernandes A, Sharma S, Bendor-Grynbaum C, et al. Mycobacterium tuberculosis associated septic shock. Am J Respir Crit Care Med, 2020, 201: A6926.
|
14. |
Shimabukuro-Vornhagen A, Godel P, Subklewe M, et al. Cytokine release syndrome. J Immunother Cancer, 2018, 6(1): 56.
|
15. |
Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol, 2017, 39(5): 517-528.
|
16. |
Reyes M, Filbin MR, Bhattacharyya RP, et al. An immune-cell signature of bacterial sepsis. Nat Med, 2020, 26(3): 333-340.
|
17. |
Valade S, Raskine L, Aout M, et al. Tuberculosis in the intensive care unit: a retrospective descriptive cohort study with determination of a predictive fatality score. Can J Infect Dis Med Microbiol, 2012, 23(4): 173-178.
|
18. |
Goldberg B, Sichtig H, Geyer C, et al. Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics. mBio, 2015, 6(6): e01888-15.
|
19. |
中华医学会结核病学分会. 肺结核诊断和治疗指南. 中国实用乡村医生杂志, 2013, 20(2): 7-11.
|
20. |
Long MW, Snider DE Jr, Farer LS. U. S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Am Rev Respir Dis, 1979, 119(6): 879-894.
|
21. |
Koegelenberg CF, Nortje A, Lalla U, et al. The pharmacokinetics of enteral antituberculosis drugs in patients requiring intensive care. S Afr Med J, 2013, 103(6): 394-398.
|
22. |
Sin JH, Elshaboury RH, Hurtado RM, et al. Therapeutic drug monitoring of antitubercular agents for disseminated Mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltration. J Clin Pharm Ther, 2018, 43(2): 291-295.
|
23. |
Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin, 2006, 22(2): 255-271.
|
24. |
Critchley JA, Young F, Orton L, et al. Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis, 2013, 13(3): 223-237.
|
25. |
Yang JY, Han M, Koh Y, et al. Effects of corticosteroids on critically ill pulmonary tuberculosis patients with acute respiratory failure: a propensity analysis of mortality. Clin Infect Dis, 2016, 63(11): 1449-1455.
|